A new study from Japan has shown that the protein mucin 21 (MUC21) can be used to help pathologists (doctors who study disease) distinguish between a mesothelioma diagnosis and adenocarcinoma diagnosis—a type of non-small cell lung cancer that accounts for roughly 40% of lung cancer cases and is a possible mesothelioma misdiagnosis. However, unlike other proteins
The post MUC21 Biomarker May Improve Mesothelioma Diagnosis Accuracy appeared first on Mesothelioma Help Now.
source http://www.mesotheliomahelpnow.com/blog/muc21-biomarker-may-improve-mesothelioma-diagnosis-accuracy/
No comments:
Post a Comment